Pharmaceuticals, Biotechnology and Life Sciences
Libervant™ NDA resubmission accepted, PDUFA goal date of December 23, 2021On track to report top-line data from Phase 1 study for…
MELBOURNE, Australia, Aug. 03, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce…
TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) — Avicanna Inc. (the “Company” or “Avicanna”) (TSX: AVCN) announces that the Ontario Securities…
BOSTON, Aug. 03, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development…
– Call-in on Tuesday, August 3rd at 9 a.m. ET -AUSTIN, Texas, Aug. 02, 2021 (GLOBE NEWSWIRE) — Cassava Sciences,…
Daix (France), August 2, 2021 (GLOBE NEWSWIRE) – Inventiva S.A. (NASDAQ: IVA – EURONEXT PARIS: IVA) (the “Company”), a clinical-stage…
JERSEY CITY, N.J., Aug. 02, 2021 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome…
Off-the-Shelf CAR T-cell Product Candidate Derived from Clonal Master iPSC Line with Novel CD19-specific 1XX CAR Integrated into TRAC Locus…
SHANGHAI, China, July 30, 2021 (GLOBE NEWSWIRE) — ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading integrated solutions…
LAS VEGAS, July 30, 2021 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a leading developer and manufacturer of science-forward,…